IDBS Wins Innovation in Business at Prestigious Business Awards
IDBS, the global provider of data management solutions for research and development companies, is proud to have won the Innovation in Business Award at the Surrey Business Awards 2009.
IDBS, the global provider of data management solutions for research and development companies, is proud to have won the Innovation in Business Award at the Surrey Business Awards 2009.
New $15m facility will "meet growing business need for its integrated product development and commercial services."
IDBS, a leading provider of innovative data management solutions to multinational R&D organizations, announced that it has concluded an unconditional agreement to acquire InforSense Ltd (InforSense), a company providing award-winning scientific and business intelligence (BI) technologies, in an all-cash transaction. The acquisition will complete in July.
GVK Biosciences (GVK BIO) today announced that it has entered into an agreement with Dr. Kimito Funatsu, University of Tokyo on its GPCR Databases. Dr. Kimito Funatsu, a world-renowned professor, teaches at University of Tokyo’s prestigious Department of Chemical System Engineering.
Various methods are available to ensure the quality of medical translations – but some are more effective than others.
Dutch biotechnology company Amarna Therapeutics B.V. and the Netherlands Organisation for Applied Scientific Research TNO today announced that they have entered into a collaboration agreement to further develop Amarna's viral gene delivery platform SVac.
IDBS has announced that the Immunovirology Division of the French Atomic Energy Agency (Commissariat à l’Ènergie Atomique, CEA) has selected E-WorkBook for biology (BioBook) to capture, collate, analyze and share experimental data across its multi-user immunovirology research projects.
IDBS, a leading provider of innovative data management solutions for research science, announces the formation of a strategic relationship with the Department of Chemistry at the University of Cambridge.
Glycotope Biotechnology, an established CMO equipped with state-of-the-art technologies and more than 25 years of experiences in GMP production of biotherapeutics announces the approval for fill finish of clinical grade material. Since then, the company has successfully completed five fill and finish projects for different customers.
Digital pen and paper technology captures handwritten clinical data electronically, quickly and securely to save time and cost in drug discovery process.